HF
IPSC icon

HRT Financial’s Century Therapeutics IPSC Stock Holding History

HRT Financial’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,113
Closed -$9K – 3578
2025
Q3 		$9K Sell
18,113
-92,951
-84% -$50.1K ﹤0.01% 2754
2025
Q2 		$62K Buy
+111,064
New +$59.6K ﹤0.01% 2279
2024
Q1 		– Sell
-17,528
Closed -$58K – 2668
2023
Q4 		$58K Buy
+17,528
New +$31.9K ﹤0.01% 1943

Other funds holding IPSC

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

HRT Financial's IPSC Position: Q4 2025 in Review

HRT Financial sold out of Century Therapeutics (IPSC) in Q4 2025, closing a stake of 18,113 shares — an estimated $9K sold.

HRT Financial first reported a position in IPSC in Q4 2023 and held it in 3 quarters. The position peaked at $62K in Q2 2025. 47 funds tracked by Wall St. Rank hold IPSC as of Q4 2025.

  • HRT Financial reported no remaining Century Therapeutics position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 18,113 Century Therapeutics shares in Q4 2025, an estimated $9K.
  • HRT Financial first reported a position in Century Therapeutics in Q4 2023 and held it in 3 quarters.
  • HRT Financial's Century Therapeutics position peaked at $62K in Q2 2025.
  • 47 funds tracked by Wall St. Rank held Century Therapeutics as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.